Nasonex (Mometasone Furoate)

Mometasone furoate is a synthetic corticosteroid that binds to glucocorticoid receptors in the cells lining the nasal mucosa. This binding alters gene expression, suppressing the release of inflammatory cytokines, chemokines and other mediators. The resulting decrease in inflammatory cell infiltration and vascular permeability reduces swelling, mucus formation and nasal congestion.

The prescribed dose is determined by the treating physician based on the patient’s age, condition severity and response. Typically, one or two sprays per nostril once daily are used, but exact dosing must follow the healthcare provider’s instructions.

Safety data for mometasone furoate in pregnancy are limited, and the drug is generally classified as Category C, meaning risk cannot be ruled out. It should be used only if the potential benefit justifies the potential risk. Breastfeeding mothers should consult their physician, as small amounts may be excreted in milk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nasonex contains mometasone furoate, which has high topical potency and low systemic bioavailability, similar to other agents such as fluticasone propionate or budesonide. Compared with some alternatives, mometasone may offer once‑daily dosing and a favorable safety profile, but choice depends on individual response, physician preference and formulary considerations.

Store Nasonex at room temperature, below 25 °C (77 °F). Keep the spray in its original packaging, protect it from moisture and direct sunlight, and ensure the cap is tightly closed when not in use.

Nasonex is a metered‑dose nasal spray. Before first use, prime the device as instructed. Tilt the head slightly forward, insert the tip into each nostril, and press the actuator while breathing in gently through the nose. Avoid spraying directly onto the nasal septum to reduce irritation.

Although rare, serious adverse effects can include nasal septal perforation, severe allergic reactions such as anaphylaxis, and ocular complications like cataracts or increased intra‑ocular pressure. Patients should report any unusual symptoms promptly to their healthcare provider.

Nasonex is contraindicated in individuals with known hypersensitivity to mometasone furoate or any component of the formulation. It should also be avoided in patients with active untreated nasal or sinus infections, and caution is advised in those with uncontrolled glaucoma, cataracts, or systemic fungal infections.